Kite Pharma, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Kite Pharma, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year One of $4.03 million as of 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2017-02-28
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $4.03M.
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $4.18M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2016-12-31 | $4.03M 10-K · filed 2017-02-28 |
| 2015-12-31 | $4.18M 10-K · filed 2016-02-29 |